156 related articles for article (PubMed ID: 34555263)
1. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.
Taylor JA; Burnell M; Ryan A; Karpinskyj C; Kalsi JK; Taylor H; Apostolidou S; Sharma A; Manchanda R; Woolas R; Campbell S; Parmar M; Singh N; Jacobs IJ; Menon U; Gentry-Maharaj A
BJOG; 2022 Jan; 129(1):110-118. PubMed ID: 34555263
[TBL] [Abstract][Full Text] [Related]
2. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Singh N; Ryan A; Karpinskyj C; Carlino G; Taylor J; Massingham SK; Raikou M; Kalsi JK; Woolas R; Manchanda R; Arora R; Casey L; Dawnay A; Dobbs S; Leeson S; Mould T; Seif MW; Sharma A; Williamson K; Liu Y; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Jacobs IJ; Parmar M
Lancet; 2021 Jun; 397(10290):2182-2193. PubMed ID: 33991479
[TBL] [Abstract][Full Text] [Related]
4. Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gentry-Maharaj A; Glazer C; Burnell M; Ryan A; Berry H; Kalsi J; Woolas R; Skates SJ; Campbell S; Parmar M; Jacobs I; Menon U
BMJ Open; 2017 Mar; 7(3):e011822. PubMed ID: 28264823
[TBL] [Abstract][Full Text] [Related]
5. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
[TBL] [Abstract][Full Text] [Related]
6. Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gentry-Maharaj A; Taylor H; Kalsi J; Ryan A; Burnell M; Sharma A; Apostolidou S; Campbell S; Jacobs I; Menon U
BMJ Open; 2014 Mar; 4(3):e004421. PubMed ID: 24589827
[TBL] [Abstract][Full Text] [Related]
7. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
8. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study.
Cusimano MC; Chiu M; Ferguson SE; Moineddin R; Aktar S; Liu N; Baxter NN
BMJ; 2021 Dec; 375():e067528. PubMed ID: 34880044
[TBL] [Abstract][Full Text] [Related]
9. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
Rice MS; Hankinson SE; Tworoger SS
Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
[TBL] [Abstract][Full Text] [Related]
10. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
11. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
Darelius A; Kristjansdottir B; Dahm-Kähler P; Strandell A
Int J Cancer; 2021 Oct; 149(8):1544-1552. PubMed ID: 34152012
[TBL] [Abstract][Full Text] [Related]
12. Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study.
Sharma A; Gentry-Maharaj A; Burnell M; Fourkala EO; Campbell S; Amso N; Seif MW; Ryan A; Parmar M; Jacobs I; Menon U;
BJOG; 2012 Jan; 119(2):207-19. PubMed ID: 21762355
[TBL] [Abstract][Full Text] [Related]
13. Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.
Faber MT; Horsbøl TA; Baandrup L; Dalton SO; Kjaer SK
Gynecol Oncol; 2022 Jan; 164(1):98-104. PubMed ID: 34763941
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma.
Nasioudis D; Mulugeta-Gordon L; McMinn E; Byrne M; Ko EM; Cory L; Haggerty AF; Latif NA
Int J Gynecol Cancer; 2021 Mar; 31(3):480-483. PubMed ID: 33649017
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting visualization of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Sharma A; Burnell M; Gentry-Maharaj A; Campbell S; Amso NN; Seif MW; Fletcher G; Brunel C; Turner G; Rangar R; Ryan A; Jacobs I; Menon U;
Ultrasound Obstet Gynecol; 2013 Oct; 42(4):472-7. PubMed ID: 23456790
[TBL] [Abstract][Full Text] [Related]
17. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Jacobs IJ; Menon U; Ryan A; Gentry-Maharaj A; Burnell M; Kalsi JK; Amso NN; Apostolidou S; Benjamin E; Cruickshank D; Crump DN; Davies SK; Dawnay A; Dobbs S; Fletcher G; Ford J; Godfrey K; Gunu R; Habib M; Hallett R; Herod J; Jenkins H; Karpinskyj C; Leeson S; Lewis SJ; Liston WR; Lopes A; Mould T; Murdoch J; Oram D; Rabideau DJ; Reynolds K; Scott I; Seif MW; Sharma A; Singh N; Taylor J; Warburton F; Widschwendter M; Williamson K; Woolas R; Fallowfield L; McGuire AJ; Campbell S; Parmar M; Skates SJ
Lancet; 2016 Mar; 387(10022):945-956. PubMed ID: 26707054
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley J; Burnell M; Gentry-Maharaj A; Ryan A; Neophytou C; Apostolidou S; Karpinskyj C; Kalsi J; Mould T; Woolas R; Singh N; Widschwendter M; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
Gynecol Oncol; 2020 Aug; 158(2):316-322. PubMed ID: 32561125
[TBL] [Abstract][Full Text] [Related]
20. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS).
Sharma A; Apostolidou S; Burnell M; Campbell S; Habib M; Gentry-Maharaj A; Amso N; Seif MW; Fletcher G; Singh N; Benjamin E; Brunell C; Turner G; Rangar R; Godfrey K; Oram D; Herod J; Williamson K; Jenkins H; Mould T; Woolas R; Murdoch J; Dobbs S; Leeson S; Cruickshank D; Fourkala EO; Ryan A; Parmar M; Jacobs I; Menon U
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):338-44. PubMed ID: 22911637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
